🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a prospective Phase IV study to determine if the use of Evero...
Status
Enrolling By Invitation
Location
University of California at San Francisco
Start Date
2014-03
Trial ID
NCT02081755
Treatments Being Tested
This study is a single-arm, open-label, multi-institutional Phase I/II tria...
Status
Completed
Location
Lombardi Comprehensive Cancer Center
Start Date
2017-05-04
Trial ID
NCT02985125
Treatments Being Tested
It is estimated that women lose around 20-25% of bone mass during the 5-10 ...
Status
Active Not Recruiting
Location
Odense University Hospital
Start Date
2024-10-14
Trial ID
NCT06789900
Treatments Being Tested
In this research study, the investigators are evaluating the clinical benef...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2014-09
Trial ID
NCT02201212
Treatments Being Tested
The primary objective of the study is to evaluate the safety of idelalisib ...
Status
Completed
Location
Clearview Cancer Institute
Start Date
2010-03-25
Trial ID
NCT01088048
The study is designed as an open-label, prospective, single arm, multicente...
Status
Completed
Location
Charité-Universitätsmedizin, Medizinische Klinik m. S. Hepatologie und Gastroenterologie, Campus Virchow-Klinikum
Start Date
2015-08
Trial ID
NCT02113800
Treatments Being Tested
This Phase III, randomized, open label, multicenter study will evaluate the...
Status
Active Not Recruiting
Location
The First Affiliated Hispital of Bengbu Medical University
Start Date
2024-11-14
Trial ID
NCT06680921
Treatments Being Tested
RAD001 continues to be investigated as an anticancer agent on new indicatio...
Status
Unknown
Location
Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences
Start Date
2010-07
Trial ID
NCT01175096
Treatments Being Tested
RATIONALE: Everolimus may stop the growth of tumor cells by blocking some o...
Status
Unknown
Location
Leiden University Medical Center
Start Date
2010-05
Trial ID
NCT01118065
Treatments Being Tested
Hypothesis: Different patients have different biomarkers, if doctors know a...
Status
Unknown
Location
Gastrointestinal Hospital, Sun Yat-sen University
Start Date
2013-12
Trial ID
NCT02013089
Treatments Being Tested